Bausch Health Companies Inc. BHC reported a strong third quarter in 2026, with total revenue rising to $2.9 billion, up 52.75% from a year earlier. Gross profit increased to $2.2 billion, while operating profit climbed to $983 million, reflecting sharply improved profitability across the business.
Net income attributable to common shareholders came in at $436 million, and diluted earnings per share reached $1.17, both showing major year-over-year gains. Cash from operating activities doubled to $814 million, underscoring stronger cash generation during the quarter.
The company ended the period with $2.5 billion in cash and cash equivalents, while total liabilities edged down to $25.8 billion. Capital spending remained modest at $66 million, helping support the company’s improved cash position. Shares rose 13.73% after the market close following the release.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Bausch Health Companies Inc. Insider Trading Activity
Bausch Health Companies Inc. insiders have traded $BHC stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $BHC stock by insiders over the last 6 months:
- AIMEE J. LENAR (President, US Pharma) sold 36,827 shares for an estimated $258,893
- FRANK D. LEE sold 24,456 shares for an estimated $132,796
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Bausch Health Companies Inc. Hedge Fund Activity
We have seen 89 institutional investors add shares of Bausch Health Companies Inc. stock to their portfolio, and 102 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NOMURA HOLDINGS INC removed 8,586,952 shares (-95.6%) from their portfolio in Q2 2026, for an estimated $42,333,673
- SG AMERICAS SECURITIES, LLC added 5,520,961 shares (+37278.6%) to their portfolio in Q2 2026, for an estimated $27,218,337
- NUVEEN, LLC removed 3,609,530 shares (-95.0%) from their portfolio in Q2 2026, for an estimated $17,794,982
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 2,186,244 shares (+inf%) to their portfolio in Q2 2026, for an estimated $10,778,182
- OAKTREE CAPITAL MANAGEMENT LP removed 1,270,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $6,261,100
- WALLEYE CAPITAL LLC removed 1,177,080 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $5,803,004
- GENDELL JEFFREY L added 1,067,251 shares (+35.9%) to their portfolio in Q2 2026, for an estimated $5,261,547
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
